Rezultati pretrage autora

1

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays od Kathy S. Albain, Soonmyung Paik, Laura van’t Veer

Izdano 2009

Preuzmi cijeli tekst
Revisão

Spremi u popis

Spremljeno u:
2

The MINDACT trial: The first prospective clinical validation of a genomic tool od Fátima Cardoso, Martine Piccart, Laura Van't Veer, Emiel J. Rutgers

Izdano 2007

Preuzmi cijeli tekst Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:
3

Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary od John Bridgewater, Ryan K. van Laar, Arno Floore, Laura van’t Veer

Izdano 2008

Preuzmi cijeli tekst Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:
4

Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity od Denise M. Wolf, Marc E. Lenburg, Christina Yau, Aaron Boudreau, Laura van ‘t Veer

Izdano 2014

Preuzmi cijeli tekst Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:
5

Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma od Patti Curl, Igor Vujic, Laura van ‘t Veer, Susana Ortiz‐Urda, James G. Kahn

Izdano 2014

Preuzmi cijeli tekst Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:
6

TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. od Guus Hateboer, H. T. Marc Timmers, AK Rustgi, Marc Billaud, Laura van ‘t Veer, René Bernards

Izdano 1993

Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:
7

E2F-5, a New E2F Family Member That Interacts with p130 In Vivo od E. Marielle Hijmans, P. Mathijs Voorhoeve, Roderick L. Beijersbergen, Laura van ‘t Veer, René Bernards

Izdano 1995

Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:
8

Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability od Josien C.C. Scheepens, Laura van ‘t Veer, Laura J. Esserman, Jeffrey Belkora, Rita A. Mukhtar

Izdano 2021

Preuzmi cijeli tekst Preuzmi cijeli tekst
Revisão

Spremi u popis

Spremljeno u:
9

Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance od Pavel Stejskal, Hani Goodarzi, Josef Srovnal, Marián Hajdúch, Laura van ‘t Veer, Mark Jesus M. Magbanua

Izdano 2023

Preuzmi cijeli tekst Preuzmi cijeli tekst
Revisão

Spremi u popis

Spremljeno u:
10

Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex. od Mark J. Alkema, Marieke Bronk, Els Verhoeven, Arie P. Otte, Laura van ‘t Veer, A Berns, Maarten van Lohuizen

Izdano 1997

Preuzmi cijeli tekst Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:
11

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature od Michael Knauer, Fátima Cardoso, Jelle Wesseling, Philippe L. Bédard, Sabine C. Linn, Emiel J. Rutgers, Laura van ‘t Veer

Izdano 2010

Preuzmi cijeli tekst Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:
12

Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis od Alexandra J. van den Broek, Marjanka K. Schmidt, Laura van ‘t Veer, Rob A.�E.�M. Tollenaar, Flora E. van Leeuwen

Izdano 2015

Preuzmi cijeli tekst Preuzmi cijeli tekst
Revisão

Spremi u popis

Spremljeno u:
13

Comparison of prognostic gene expression signatures for breast cancer od Benjamin Haibe‐Kains, Christine Desmedt, Fanny Piette, Marc Buyse, Fátima Cardoso, Laura van’t Veer, Martine Piccart, Gianluca Bontempi, Christos Sotiriou

Izdano 2008

Preuzmi cijeli tekst Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:
14

Expression profiling predicts outcome in breast cancer od Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver, Yudong D. He, Augustinus A. M. Hart, René Bernards, Stephen Friend

Izdano 2002

Preuzmi cijeli tekst Preuzmi cijeli tekst
Carta

Spremi u popis

Spremljeno u:
15

Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer od Rob Michalides, Alexander Griekspoor, Astrid Balkenende, Desirée Verwoerd, Lennert Janssen, Kees Jalink, Arno Floore, Arno Velds, Laura van 't Veer, Jacques Neefjes

Izdano 2004

Preuzmi cijeli tekst Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:
16

N-ras mutations in human cutaneous melanoma from sun-exposed body sites. od Laura van ‘t Veer, Boudewijn Burgering, Rogier Versteeg, A J Boot, D. J. Ruiter, Susanne Osanto, Peter I. Schrier, Johannes L. Bos

Izdano 1989

Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:
17

A protocol for building and evaluating predictors of disease state based on microarray data od Lodewyk F.A. Wessels, Marcel J. T. Reinders, A.A.M. Hart, Cor J. Veenman, H. Dai, Yudong D. He, Laura van ‘t Veer

Izdano 2005

Preuzmi cijeli tekst Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:
18

Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients od James M. Ford, Sophie Adams, Taylor Sittler, Jeroen van den Akker, Salina Chan, Ofri Leitner, Lauren Ryan, Elad Gil, Laura van ’t Veer

Izdano 2017

Preuzmi cijeli tekst Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:
19

A combined oncogenic pathway signature ofBRAF,KRASandPI3KCAmutation improves colorectal cancer classification and cetuximab treatment prediction od Sun Tian, Iris Simón, Vı́ctor Moreno, Paul Roepman, Josep Tabernero, Mireille H.J. Snel, Laura van’t Veer, Ramón Salazar, René Bernards, Gabriel Capellà

Izdano 2012

Preuzmi cijeli tekst Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:
20

Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4–9 positive lymph nodes od Mahasti Saghatchian, Stella Mook, Giancarlo Pruneri, Giuseppe Viale, Annuska M. Glas, Sylvie Guérin, Fátima Cardoso, Martine Piccart, Thomas Tursz, Suzette Delaloge, Laura van’t Veer

Izdano 2013

Preuzmi cijeli tekst
Artigo

Spremi u popis

Spremljeno u:

Rezultati pretrage - Laura Van't Veer

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays od Kathy S. Albain, Soonmyung Paik, Laura van’t Veer

The MINDACT trial: The first prospective clinical validation of a genomic tool od Fátima Cardoso, Martine Piccart, Laura Van't Veer, Emiel J. Rutgers

Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary od John Bridgewater, Ryan K. van Laar, Arno Floore, Laura van’t Veer

Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity od Denise M. Wolf, Marc E. Lenburg, Christina Yau, Aaron Boudreau, Laura van ‘t Veer

Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma od Patti Curl, Igor Vujic, Laura van ‘t Veer, Susana Ortiz‐Urda, James G. Kahn

TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. od Guus Hateboer, H. T. Marc Timmers, AK Rustgi, Marc Billaud, Laura van ‘t Veer, René Bernards

E2F-5, a New E2F Family Member That Interacts with p130 In Vivo od E. Marielle Hijmans, P. Mathijs Voorhoeve, Roderick L. Beijersbergen, Laura van ‘t Veer, René Bernards

Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability od Josien C.C. Scheepens, Laura van ‘t Veer, Laura J. Esserman, Jeffrey Belkora, Rita A. Mukhtar

Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance od Pavel Stejskal, Hani Goodarzi, Josef Srovnal, Marián Hajdúch, Laura van ‘t Veer, Mark Jesus M. Magbanua

Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex. od Mark J. Alkema, Marieke Bronk, Els Verhoeven, Arie P. Otte, Laura van ‘t Veer, A Berns, Maarten van Lohuizen

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature od Michael Knauer, Fátima Cardoso, Jelle Wesseling, Philippe L. Bédard, Sabine C. Linn, Emiel J. Rutgers, Laura van ‘t Veer

Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis od Alexandra J. van den Broek, Marjanka K. Schmidt, Laura van ‘t Veer, Rob A.�E.�M. Tollenaar, Flora E. van Leeuwen

Comparison of prognostic gene expression signatures for breast cancer od Benjamin Haibe‐Kains, Christine Desmedt, Fanny Piette, Marc Buyse, Fátima Cardoso, Laura van’t Veer, Martine Piccart, Gianluca Bontempi, Christos Sotiriou

Expression profiling predicts outcome in breast cancer od Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver, Yudong D. He, Augustinus A. M. Hart, René Bernards, Stephen Friend

Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer od Rob Michalides, Alexander Griekspoor, Astrid Balkenende, Desirée Verwoerd, Lennert Janssen, Kees Jalink, Arno Floore, Arno Velds, Laura van 't Veer, Jacques Neefjes

N-ras mutations in human cutaneous melanoma from sun-exposed body sites. od Laura van ‘t Veer, Boudewijn Burgering, Rogier Versteeg, A J Boot, D. J. Ruiter, Susanne Osanto, Peter I. Schrier, Johannes L. Bos

A protocol for building and evaluating predictors of disease state based on microarray data od Lodewyk F.A. Wessels, Marcel J. T. Reinders, A.A.M. Hart, Cor J. Veenman, H. Dai, Yudong D. He, Laura van ‘t Veer

Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients od James M. Ford, Sophie Adams, Taylor Sittler, Jeroen van den Akker, Salina Chan, Ofri Leitner, Lauren Ryan, Elad Gil, Laura van ’t Veer

Alati za pretragu:

Povezani predmeti